[1] Juni, P.; Rutjes, A.W.; Dieppe, P.A. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs? BMJ. 2002, 324, 1287-1288.
[2] Patrono, C.; Patrignani, P.; Garcia, R.L. Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J. Clin. Invest. 2001, 108, 7-13.
[3] Cashman, J.N. The mechanisms of action of NSAIDs in analgesia. Drugs. 1996, 5, 13-23.
[4] Todd, P.A.; Sorkin, E.M. Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs. 1988, 35, 244-285.
[5] Romsing, J.; Ostergaard, D.; Drozdziewicz, D.; Schultz, P.; Ravn, G. Diclofenac or acetaminophen for analgesia in paediatric tonsillectomy outpatients. Acta Anaesthesiol Scand. 2000, 44, 291-295.
[6] Hartmann, J.; Bartels, P.; Mau, U.; Witter, M.; Tumpling, W.V.; Hofmann, J.; Nietzschmann, E. Degradation of the drug diclofenac in water by sonolysis in presence of catalysts. Chemosphere. 2008, 70, 453-461.
[7] Zhang, N.; Liu, G.; Liu, H.; Wang, Y.; He, Z.; Wang, G. Diclofenac photodegradation under simulated sunlight: Effect of different forms of nitrogen and kinetics. J. Hazard. Mater. 2011, 192, 411-418.
[8] Ioele, G.; Tavano, L.; De Luca, M.; Ragno, G.; Picci, N.; Muzzalupo, R. Photostability and ex-vivo permeation studies on diclofenac in topical niosomal formulations. Int. J. Pharm. 2015, 494, 490-497.
[9] Salgado, R.; Pereira, V.J.; Carvalho, G.; Soeiro, R.; Gaffney, V.; Almeida, C.; Vale, C.V.; Ferreira, E.; Benoliel, M.J.; Ternes, T.A.; Oehmen, A.; Reis, M.A.; Noronha, J.P. Photodegradation kinetics and transformation products of ketoprofen, diclofenac and atenolol in pure water and treated wastewater. J. Hazard. Mater. 2013, 244-245, 516-527.
[10] Fini, A.; Garuti, M.; Fazio, G.; Alvarez-Fuentes, J.; Holgado, M.A. Diclofenac salts. I. Fractal and thermal analysis of sodium and potassium diclofenac salts. J. Pharm. Sci. 2001, 90, 2049-2057.
[11] Reck, G.; Faust, G.; Dietz, G. X-ray crystallographic studies of diclofenac-sodium-structural analysis of diclofenac-sodium tetrahydrate. Pharmazie. 1988, 43, 771-774.
[12] Bartolomei, M.; Bertocchi, P.; Antoniella, E.; Rodomonte, A. Physico-chemical characterisation and intrinsic dissolution studies of a new hydrate form of diclofenac sodium: comparison with anhydrous form. J. Pharm. Biomed. Anal. 2006, 40, 1105-1113.
[13] Soares, G.A.; de Castro, A.D.; Cury, B.S.; Evangelista, R.C. Blends of cross-linked high amylose starch/pectin loaded with diclofenac. Carbohydr. Polym. 2013, 91, 135-142.
[14] Cwiertnia, B.; Hladon, T.; Stobiecki, M. Stability of diclofenac sodium in the inclusion complex with beta-cyclodextrin in the solid state. J. Pharm. Pharmacol. 1999, 51, 1213-1218.
[15] Fini, A.; Fazio, G.; Rabasco, A.M.; Fernandez-Hervas, M.J.; Holgado, M.A. Effect of the temperature on a hydrate diclofenac salt. Int. J. Pharm. 1999, 181, 95-106.
[16] Nita, L E.; Chiriac, A.P.; Diaconu, A.; Tudorachi, N.; Mititelu-Tartau, L. Multifunctional nanogels with dual temperature and pH responsiveness. Int. J. Pharm. 2016, 515, 165-175.
[17] Ioele, G.; De Luca, M.; Tavano, L.; Ragno, G. The difficulties for a photolabile drug in topical formulations: the case of diclofenac. Int. J. Pharm. 2014, 465, 284-290.
[18] Iliescu, T.; Baia, M.; Miclaus, V. A Raman spectroscopic study of the diclofenac sodium-beta-cyclodextrin interaction. Eur. J. Pharm. Sci. 2004, 22, 487-495. |